SCHEMBL1425829

SCHEMBL1425829

BrCc1nc(-c2ccc(OCc3ccccc3)cc2)ns1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 2/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 1/20 0.46
MGAM O43451 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
GSTP1 P09211 1/20 0.44
PRMT5 O14744 6/20 0.44
MAOB P27338 3/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
PTGS1 P23219 1/20 0.44
SLC6A2 P23975 1/20 0.44
CYP2C19 P33261 1/20 0.44
PTGS2 P35354 1/20 0.44
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1425713 0.86 MAOB (0.50) RAB9ASMN1; SMN2GAAMEN1NPC1
SCHEMBL222716 0.80 PARP10 (0.51) GAAMGAMSIMGAM2GSTP1
SCHEMBL12811783 0.78 RAB9A (0.49) RAB9ASMN1; SMN2NPC1POLBLMNA
SCHEMBL3649527 0.77 NR4A2 (0.56) MEN1KMT2AGSTP1PRMT5MAOB
SCHEMBL1425556 0.77 ADORA3 (0.50) RAB9ASMN1; SMN2GAANPC1PTGS2
SCHEMBL13258018 0.73 GSTP1 (0.58) RAB9ASMN1; SMN2GAAGSTP1MAOB
SCHEMBL1425593 0.73 ALDH1A1 (0.51) MEN1KMT2APRMT5MAOBLMNA
SCHEMBL197017 0.72 LMNA (0.72) RAB9ASMN1; SMN2GAAMEN1NPC1
SCHEMBL1425924 0.71 NPC1 (0.46) RAB9ASMN1; SMN2MEN1NPC1KMT2A
SCHEMBL4107347 0.71 RXFP1 (0.40) RAB9ASMN1; SMN2MEN1NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492414-B2 Antibacterial agents BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-07-23 US disclosed
US-8492414-B2 Antibacterial agents BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-07-23 US disclosed
EP-2200991-B1 ANTIBACTERIAL AGENTS BIOTA EUROPE LTD (GB) 2011-03-23 EP disclosed
US-20100273837-A1 ANTIBACTERIAL AGENTS BIOTA EUROPE LTD. (GB) 2010-10-28 US disclosed
US-20100273837-A1 ANTIBACTERIAL AGENTS BIOTA EUROPE LTD. (GB) 2010-10-28 US disclosed
EP-2200991-A1 ANTIBACTERIAL AGENTS Biota Europe Ltd (GB) 2010-06-30 EP disclosed
WO-2009037485-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2009-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273837-A1 ANTIBACTERIAL AGENTS SQOR, SCO2, CYCS RAB9A 840/4885SMN1; SMN2 3787/4885GAA 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.